Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Director departure
Appointed director

BIO-TECHNE Corp (TECH) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 4/A Bohnen Shane (SVP - General Counsel) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 148 restricted stock units @ $0
Granted 16,302 options to buy @ $84.61, valued at $1.4M
08/17/2023 4 Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 12,798 restricted stock units @ $0
Granted 34,442 options to buy @ $84.61, valued at $2.9M
Granted 45,923 options to buy @ $84.61, valued at $3.9M
08/17/2023 4 Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 8,191 restricted stock units @ $0
Granted 22,043 options to buy @ $84.61, valued at $1.9M
Granted 29,391 options to buy @ $84.61, valued at $2.5M
08/17/2023 4 Bohnen Shane (SVP - General Counsel) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 4,432 restricted stock units @ $0
Granted 11,928 options to buy @ $84.61, valued at $1M
Granted 15,904 options to buy @ $84.61, valued at $1.3M
08/17/2023 4 Kummeth Charles R. (CEO) has filed a Form 4 on BIO-TECHNE Corp
Txns: Exercised 17,632 shares @ $0
Paid exercise price by delivering 8,675 shares @ $84.61, valued at $734k
Granted 59,095 restricted stock units @ $0
08/17/2023 4 Geist William (PRESIDENT, PROTEIN SCIENCES) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 8,377 restricted stock units @ $0
Granted 22,544 options to buy @ $84.61, valued at $1.9M
Granted 30,059 options to buy @ $84.61, valued at $2.5M
08/11/2023 4 Kummeth Charles R. (CEO) has filed a Form 4 on BIO-TECHNE Corp
Txns: Gifted 9,008 shares @ $0
08/08/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/08/2023 4 Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp
Txns: Paid exercise price by delivering 6,335 shares @ $82.17, valued at $520.5k
Exercised 12,876 restricted stock units @ $0
08/08/2023 4 Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp
Txns: Paid exercise price by delivering 4,139 shares @ $82.17, valued at $340.1k
Exercised 8,060 restricted stock units @ $0
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2023 4 Kummeth Charles R. (CEO) has filed a Form 4 on BIO-TECHNE Corp
Txns: Paid exercise price by delivering 390,727 shares @ $81.63, valued at $31.9M
Exercised 616,676 options to buy @ $26.65, valued at $16.4M
06/09/2023 4 Kummeth Charles R. (CEO) has filed a Form 4 on BIO-TECHNE Corp
Txns: Sold 322 shares @ $83, valued at $26.7k
05/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2023 4 Bohnen Shane (SVP - General Counsel) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 6,778 restricted stock units @ $0
Granted 3,928 options to buy @ $73.76, valued at $289.7k
04/04/2023 3 Bohnen Shane (SVP - General Counsel) has filed a Form 3 on BIO-TECHNE Corp
01/06/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/31/2022 4 Bushman Julie L (Director) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 338 shares @ $0
Granted 865 options to buy @ $295.77, valued at $255.8k
10/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
08/25/2022 4 Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp
Txns: Exercised 663 options to buy @ $150.78, valued at $100k
08/17/2022 4 Geist William (PRESIDENT, PROTEIN SCIENCES) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 1,785 restricted stock units @ $0
Granted 5,550 options to buy @ $378.08, valued at $2.1M
Granted 7,400 options to buy @ $378.08, valued at $2.8M
08/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2022 4 Kummeth Charles R. (CEO) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 13,225 restricted stock units @ $0
Granted 300,000 options to buy @ $378.08, valued at $113.4M
08/17/2022 4 Furlow Brenda S. (SVP - General Counsel) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 6,166 options to buy @ $378.08, valued at $2.3M
Granted 1,984 restricted stock units @ $0
08/17/2022 4 Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 2,728 restricted stock units @ $0
Granted 8,479 options to buy @ $378.08, valued at $3.2M
Granted 11,305 options to buy @ $378.08, valued at $4.3M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy